The mounting evidence underscores the importance of AGR2 in cancer immunotherapy, particularly in hepatobiliary and pancreatic cancers, suggesting its potential as a valuable target for novel therapeutic approaches [12,16,19,20]. This evidence concerns the gene AGR2 and cancer.